Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EUPATORIUM CAPILLIFOLIUM POLLEN: 12 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
12
Total FAERS Reports
0
Deaths Reported
3
Hospitalizations
12
As Primary/Secondary Suspect
3
Life-Threatening
ALK-Abello, Inc.
Manufacturer

Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·

First Report: 20160419 · Latest Report: 20230601

What Are the Most Common EUPATORIUM CAPILLIFOLIUM POLLEN Side Effects?

#1 Most Reported
Anaphylactic reaction
5 reports (41.7%)
#2 Most Reported
Dyspnoea
4 reports (33.3%)
#3 Most Reported
Throat tightness
3 reports (25.0%)

All EUPATORIUM CAPILLIFOLIUM POLLEN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Anaphylactic reaction 5 41.7% 0 2

Who Reports EUPATORIUM CAPILLIFOLIUM POLLEN Side Effects? Age & Gender Data

Gender: 58.3% female, 41.7% male. Average age: 47.2 years. Most reports from: US. View detailed demographics →

Is EUPATORIUM CAPILLIFOLIUM POLLEN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2016 2 0 0
2017 2 0 0
2018 1 0 0
2019 1 0 0
2021 2 0 2
2023 1 0 0

View full timeline →

Other Drugs in Same Class: Allergens [CS]

Official FDA Label for EUPATORIUM CAPILLIFOLIUM POLLEN

Official prescribing information from the FDA-approved drug label.